Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of febrile neutropenia in low risk cancer patients.

× No keyword cloud information.

26 in total

Review 1. A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.

Authors: A J Croockewit; M H Bronchud; M S Aapro; M J Bargetzi; J Crown; A Gratwohl; W Lange; H Ludwig; G Martinelli; R Mertelsmann; V Nuessler; R Willemze; T J De Witte; R Zittoun; H Zwierzina
Journal: Eur J Cancer Date: 1997-10 Impact factor: 9.162

Review 2. The outpatient management of febrile neutropenia in cancer patients.

Authors: A G Freifeld; P A Pizzo
Journal: Oncology (Williston Park) Date: 1996-04 Impact factor: 2.990

3. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Authors: A Cometta; T Calandra; H Gaya; S H Zinner; R de Bock; A Del Favero; G Bucaneve; F Crokaert; W V Kern; J Klastersky; I Langenaeken; A Micozzi; A Padmos; M Paesmans; C Viscoli; M P Glauser
Journal: Antimicrob Agents Chemother Date: 1996-05 Impact factor: 5.191

Review 4. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report.

Authors: B Hampel; R Hullmann; H Schmidt
Journal: Pediatr Infect Dis J Date: 1997-01 Impact factor: 2.129

5. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial.

Authors: I A Malik; W A Khan; M Karim; Z Aziz; M A Khan
Journal: Am J Med Date: 1995-03 Impact factor: 4.965

6. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors: W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal: Antimicrob Agents Chemother Date: 1994-04 Impact factor: 5.191

7. Empirical antibiotic therapy for fever in neutropenic patients.

Authors: G P Bodey
Journal: Clin Infect Dis Date: 1993-11 Impact factor: 9.079

8. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.

Authors: J A Talcott; A Whalen; J Clark; P P Rieker; R Finberg
Journal: J Clin Oncol Date: 1994-01 Impact factor: 44.544

9. Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms.

Authors: I A Malik; W A Khan; Z Aziz; M Karim
Journal: Clin Infect Dis Date: 1994-09 Impact factor: 9.079

10. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.

Authors: A G Freifeld; T Walsh; D Marshall; J Gress; S M Steinberg; J Hathorn; M Rubin; P Jarosinski; V Gill; R C Young
Journal: J Clin Oncol Date: 1995-01 Impact factor: 44.544